Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol
about
PEGylated Adenoviruses: From Mice to MonkeysSite-Specific PEGylation of Therapeutic ProteinsEmerging and future therapies for hemophiliaAutomated solid-phase peptide synthesis to obtain therapeutic peptidesEnhancing clinical islet transplantation through tissue engineering strategies.Multivalent polymers for drug delivery and imaging: the challenges of conjugationPolyethylene glycols: An effective strategy for limiting liver ischemia reperfusion injuryPharmaceutical and toxicological properties of engineered nanomaterials for drug deliveryNew Perspective in the Formulation and Characterization of Didodecyldimethylammonium Bromide (DMAB) Stabilized Poly(Lactic-co-Glycolic Acid) (PLGA) NanoparticlesBrain delivery of proteins via their fatty acid and block copolymer modificationsDesigner lipids for drug delivery: from heads to tails.Loading PEG-catalase into filamentous and spherical polymer nanocarriers.Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Clinical utility and patient perspectives on the use of extended half-life rFIXFc in the management of hemophilia B.Agile delivery of protein therapeutics to CNSMicrophase separation in copolymers of hydrophilic PEG blocks and hydrophobic tyrosine-derived segments using simultaneous SAXS/WAXS/DSC.PEG-albumin plasma expansion increases expression of MCP-1 evidencing increased circulatory wall shear stress: an experimental study.Genetic PEGylationEnhanced brain distribution of modified aspartoacylase.Preparation and characterization of PEGylated amylin.Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirusPrevention of benzyl alcohol-induced aggregation of chymotrypsinogen by PEGylation.Nanoparticle PEGylation for imaging and therapy.IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency.Noninvasive detection of passively targeted poly(ethylene glycol) nanocarriers in tumors.Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma.Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo.PEGylation of a factor VIII-phosphatidylinositol complex: pharmacokinetics and immunogenicity in hemophilia A mice.Plasma expander and blood storage effects on capillary perfusion in transfusion after hemorrhageSelf-Assembly of Temperature-Responsive Protein-Polymer Bioconjugates.PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.Zwitterionic gel encapsulation promotes protein stability, enhances pharmacokinetics, and reduces immunogenicity.Altered biodistribution of an antibody--enzyme conjugate modified with polyethylene glycol.Protein-polymer conjugation-moving beyond PEGylation.Polymers for drug delivery systems.Influence of molecular size on the retention of polymeric nanocarrier diagnostic agents in breast ducts.One-component nanomedicineImmunological properties of conjugates of ragweed pollen antigen E with methoxypolyethylene glycol or a copolymer of D-glutamic acid and D-lysine.PRINT: A Protein Bioconjugation Method with Exquisite N-terminal Specificity.
P2860
Q24635276-572E5205-EE3E-42D5-8A93-0B11BD2B329BQ26777819-B80D755D-3CD7-4E77-99B5-4927DEA6FCB6Q26781143-5070475C-E3F6-4F01-B267-64B4BB73C7F2Q27001623-C2999C9C-1999-4544-822A-73E4C17FBD24Q27692123-99BF1BB9-DCE2-42E2-AEED-74DA442F0E5CQ27692689-FD6C1BF3-F4C0-44FC-939C-CF68ECA77C08Q28066686-CC689AA3-44F5-4465-82CE-C17A279C15DDQ28396383-6D70616E-8225-43E8-BEEF-D120B997C81FQ28546279-7C2F4727-EAF3-45C4-A456-A7080127428AQ30354932-0CA44E3C-C83C-44FF-907A-783704FE2C50Q30402374-B21F3672-28D0-485E-B97B-AB2FBA9EE133Q30475568-13122810-C035-437F-95B7-6ED96DB454FEQ33403252-C17BA3B4-9DD4-4F2A-9061-7C0DE3D3F0E0Q33847006-A98FA81B-99B6-4649-9968-4A3ECD44F05CQ34045763-C61C739A-17CB-43E3-A54F-6ECDA94CA2B5Q34079647-174E7FA1-1339-4477-A5D7-417F63C26833Q34081185-15EC595B-AA40-4F41-A39A-3546E8C92315Q34312170-09B5C6E4-C5E9-4FF7-9D28-2A998933EBB2Q34474297-6F4B469C-2B7B-46D5-A309-D4811B7FEDFAQ34616189-78F09A23-753E-4950-9D86-420F444DA2B7Q34788967-B79201B7-60DD-4321-B720-D90F5C6FA440Q34975214-7ADD109E-41DC-4FB3-A87E-61BE720BCDC9Q35062556-554D7238-3A08-4C57-A665-191B08FE2449Q35553193-993CA593-B15D-464E-AE78-A43A26AC3104Q35602714-45987B8C-0D00-419E-98EA-CDDC3751A5C4Q35671286-1010FEE0-CB9E-450C-9C8C-6B2F54884DC8Q35675340-C6C65122-582C-4F32-B4E2-4D231F991763Q35749975-5309259A-B718-42D6-8ECC-930D55751828Q35793113-CA28DE16-FDA8-44F0-9ECC-64AD77371DECQ35896555-71DDDF6C-8A06-47E3-8483-A29897EF2384Q36081046-0078E6EF-D07E-4F37-BF58-B23551B3A992Q36094371-987816F1-17E0-4312-BFD7-E3C15B19CD7AQ36120371-AF589A91-F38C-42E3-93F2-3C2BE6BDA3DFQ36135095-364EC2BC-BBB6-45BF-870D-8CBAC1C53C93Q36220152-07849786-22A3-4D40-BDFB-5A111B206A5EQ36225509-3914FEF4-755A-4C6B-A4DE-B8EECBCC547AQ36235198-AD2BD08B-9054-4535-9571-1237B4A71D20Q36307689-89C2C36E-2D1E-4C09-990C-CFFFA5BE9109Q36341221-2037064A-6167-4948-8690-3A309EC695FFQ36383059-1D84361C-B15C-497B-9626-7281C632D967
P2860
Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol
description
1977 nî lūn-bûn
@nan
1977 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Alteration of immunological pr ...... achment of polyethylene glycol
@ast
Alteration of immunological pr ...... achment of polyethylene glycol
@en
Alteration of immunological pr ...... achment of polyethylene glycol
@nl
type
label
Alteration of immunological pr ...... achment of polyethylene glycol
@ast
Alteration of immunological pr ...... achment of polyethylene glycol
@en
Alteration of immunological pr ...... achment of polyethylene glycol
@nl
prefLabel
Alteration of immunological pr ...... achment of polyethylene glycol
@ast
Alteration of immunological pr ...... achment of polyethylene glycol
@en
Alteration of immunological pr ...... achment of polyethylene glycol
@nl
P2093
P1476
Alteration of immunological pr ...... achment of polyethylene glycol
@en
P2093
A Abuchowski
N C Palczuk
P304
P407
P577
1977-06-10T00:00:00Z